Senior Director, GTM Strategy & Portfolio Planning
Core
Own the long-term go-to-market strategy for encaleret (BridgeBio's oral CaSR negative allosteric modulator for Autosomal Dominant Hypocalcemia Type 1) and shape investment prioritization across the broader endocrine portfolio.
Role type
Senior Director, GTM Strategy & Portfolio Planning
Builds
Multi-year commercial roadmap and portfolio-level resource planning framework
Domain
Biopharma / Rare Disease / Endocrinology
Required skills
Long-range portfolio strategy, market entry sequencing, competitive intelligence, payer strategy alignment, cross-functional stakeholder alignment, forecasting infrastructure, board-level presentation
Preferred skills
MBA or advanced science degree, endocrinology or nephrology therapeutic experience, AI-powered tools adoption
Technologies
AI-powered tools
Responsibilities
Own end-to-end GTM strategy for encaleret from pre-NDA through Year 1+; Lead marketing portfolio planning across the endocrine pipeline; Partner with Value & Access and Finance to align long-term payer strategy and lifecycle planning; Partner with HCP Marketing, Patient Marketing, and KOL Engagement to ensure strategy translates to field execution; Build and govern competitive intelligence and forecasting infrastructure; Develop and present long-term GTM and portfolio strategy updates to senior leadership and the Board of Directors
Seniority
Senior Director, strategic leadership